Skip to main content
. 2016 Sep 22;2016:2329483. doi: 10.1155/2016/2329483

Table 1.

Markers of bone resorption after and before zoledronic i.v. administrations.

Urinary deoxypyridinoline (U-DPD) nmol/mmol Sieric carboxyterminal cross-linked telopeptide of type I collagen (S-ICTP) pg/mL
Before the first zoledronic infusion 24,6 1549
After the first zoledronic infusion 17,22 1033
Before the second zoledronic infusion 33,2 2096
After the second zoledronic infusion 22 1362,4